BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32402130)

  • 1. What Do We Know About Remdesivir Drug Interactions?
    Yang K
    Clin Transl Sci; 2020 Sep; 13(5):842-844. PubMed ID: 32402130
    [No Abstract]   [Full Text] [Related]  

  • 2. On the molecular structure of Remdesivir for the treatment of Covid-19.
    Sheikholeslami SM; Jahanbani A; Shao Z
    Comput Methods Biomech Biomed Engin; 2021 Jul; 24(9):995-1002. PubMed ID: 33356621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remdesivir (GS-5734) in COVID-19 Therapy: The Fourth Chance.
    Moirangthem DS; Surbala L
    Curr Drug Targets; 2021; 22(12):1346-1356. PubMed ID: 33267759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remdesivir potently inhibits carboxylesterase-2 through covalent modifications: signifying strong drug-drug interactions.
    Shen Y; Eades W; Yan B
    Fundam Clin Pharmacol; 2021 Apr; 35(2):432-434. PubMed ID: 33369768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remdesivir: Critical Clinical Appraisal for COVID 19 Treatment.
    Chatterjee S
    Drug Res (Stuttg); 2021 Mar; 71(3):138-148. PubMed ID: 33124007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncertainty about the Efficacy of Remdesivir on COVID-19.
    Yoo JH
    J Korean Med Sci; 2020 Jun; 35(23):e221. PubMed ID: 32537956
    [No Abstract]   [Full Text] [Related]  

  • 7. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
    Thalha AMM; Lee YY; Besari A; Omar SFS
    J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289
    [No Abstract]   [Full Text] [Related]  

  • 8. Remdesivir: A Closer Look at Its Effect in COVID-19 Pandemic.
    Taha HR; Keewan N; Slati F; Al-Sawalha NA
    Pharmacology; 2021; 106(9-10):462-468. PubMed ID: 34515227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update Alert 2: Remdesivir for Adults With COVID-19.
    Kaka AS; MacDonald R; Linskens EJ; Wilt TJ
    Ann Intern Med; 2021 Dec; 174(12):W114-W115. PubMed ID: 34606312
    [No Abstract]   [Full Text] [Related]  

  • 10. Remdesivir: A beacon of hope from Ebola virus disease to COVID-19.
    Nili A; Farbod A; Neishabouri A; Mozafarihashjin M; Tavakolpour S; Mahmoudi H
    Rev Med Virol; 2020 Nov; 30(6):1-13. PubMed ID: 33210457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remdesivir: A giant step, or a tiptoe?
    Dickinson GM
    Clin Dermatol; 2020; 38(6):773-774. PubMed ID: 32405143
    [No Abstract]   [Full Text] [Related]  

  • 12. [Remdesivir, the antiviral hope against SARS-CoV-2].
    Reina J
    Rev Esp Quimioter; 2020 Jun; 33(3):176-179. PubMed ID: 32239125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remdesivir (Veklury) for COVID-19.
    Med Lett Drugs Ther; 2020 Nov; 62(1612):186-188. PubMed ID: 33443491
    [No Abstract]   [Full Text] [Related]  

  • 14. [The medicinal treatment of COVID-19: a brief update].
    de Boer MGJ; Gieling EM; van der Linden PD; Sinha BNM; Vollaard AM
    Ned Tijdschr Geneeskd; 2020 Nov; 164():. PubMed ID: 33331727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyanoamidine Cyclization Approach to Remdesivir's Nucleobase.
    Knapp RR; Tona V; Okada T; Sarpong R; Garg NK
    Org Lett; 2020 Nov; 22(21):8430-8435. PubMed ID: 33085486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19.
    Hashemian SM; Farhadi T; Velayati AA
    Drug Des Devel Ther; 2020; 14():3215-3222. PubMed ID: 32821086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.
    Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY
    Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Potential Antiviral Treatment for COVID-19: Remdesivir.
    O'Malley PA
    Clin Nurse Spec; 2020; 34(6):257-260. PubMed ID: 33009111
    [No Abstract]   [Full Text] [Related]  

  • 19. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
    Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 updates: Remdesivir (Veklury) in high-risk outpatients with COVID-19.
    Med Lett Drugs Ther; 2022 Feb; 64(1644):31-32. PubMed ID: 35171898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.